Sponsor pipeline

TScan Therapeutics, Inc. clinical trial pipeline

Get alerts when TScan Therapeutics, Inc.'s trials change

5 active trials 3 recruiting 1 Phase 3 10 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-16
Trial completed
Final enrollment: 238 participants (planned 300)
Primary completion confirmed: September 2026 (last estimated January 2027)
NCT06587828 A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in…

Active trials by phase

Phase 1
2
Phase 3
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07702578 A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic… AML Recruiting 2026-07-22
Phase 1
NCT05473910 A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic… AML Recruiting 2026-10-01
NCT05973487 A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally… Head and Neck Cancer Active, Not Recruiting 2025-11-17
Not specified
NCT06976736 A Long Term Follow-up Study of TScan TCR-T Products AML Recruiting 2025-09-10
NCT05812027 A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in… Head and Neck Cancer Active, Not Recruiting 2025-11-17

Disease areas by active trials

Acute Myeloid Leukemia (AML) (3) · Myelodysplastic Syndromes (MDS) (3) · Cervical Cancer (2) · Head & Neck Cancer (2) · Melanoma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Lung Cancer (1) · Ovarian Cancer (1) · Sarcoma (1)

Get alerts when TScan Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free